2025-02-01 2026-01-31 false No description of principal activity Capium Accounts Production 1.1 15421978 2025-02-01 2026-01-31 15421978 bus:AbridgedAccounts 2025-02-01 2026-01-31 15421978 bus:Micro-entities 2025-02-01 2026-01-31 15421978 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 15421978 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 15421978 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 15421978 2025-02-01 2026-01-31 15421978 2026-01-31 15421978 bus:RegisteredOffice 2025-02-01 2026-01-31 15421978 core:WithinOneYear 2026-01-31 15421978 core:AfterOneYear 2026-01-31 15421978 1 2025-02-01 2026-01-31 15421978 bus:Director1 2025-02-01 2026-01-31 15421978 bus:Director1 2026-01-31 15421978 bus:Director1 2024-01-17 2025-01-31 15421978 2024-01-17 15421978 bus:LeadAgentIfApplicable 2025-02-01 2026-01-31 15421978 2024-01-17 2025-01-31 15421978 2025-01-31 15421978 core:WithinOneYear 2025-01-31 15421978 core:AfterOneYear 2025-01-31 15421978 bus:EntityAccountantsOrAuditors 2024-01-17 2025-01-31 15421978 core:ComputerEquipment 2025-02-01 2026-01-31 15421978 core:ComputerEquipment 2026-01-31 15421978 core:ComputerEquipment 2025-01-31 15421978 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-01-31 15421978 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 15421978 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 15421978 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 15421978 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 15421978 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 15421978 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 15421978 core:Non-currentFinancialInstruments 2026-01-31 15421978 core:Non-currentFinancialInstruments 2025-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15421978
England and Wales

 

 

 

PHARMAD LTD



Abridged Accounts
 


Period of accounts

Start date: 01 February 2025

End date: 31 January 2026
  2026   2025
    £ £   £ £
Fixed assets   597      923 
Current assets 73,024      35,720   
Creditors: amount falling due within one year (8,691)     (7,213)  
Net current assets   64,333      28,507 
Total assets less current liabilities   64,930      29,430 
Creditors: amount falling due after more than one year   1,000     
Accruals and deferred income       (132)
Net assets   65,930      29,298 
 

         
Capital and reserves   65,930      29,298 
 
NOTES TO THE ACCOUNTS

General Information
PHARMAD LTD is a private company, limited by shares, registered in England and Wales, registration number 15421978, registration address 167-169 GREAT PORTLAND STREET, 5TH FLOOR, LONDON, W1W 5PF.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 0 (2025 : 0).


For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 11 May 2026 and were signed by:


--------------------------------
Man-Ho Danny Leung
Director
1